D
Acumen Pharmaceuticals, Inc. ABOS
$1.36 -$0.05-3.55% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -136.67M -116.25M -102.33M -81.67M -64.86M
Total Depreciation and Amortization 181.00K 179.00K 178.00K 173.00K 168.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 7.85M 5.24M 4.28M 4.70M 4.20M
Change in Net Operating Assets 10.87M 8.36M 11.65M 9.49M 4.87M
Cash from Operations -117.76M -102.48M -86.22M -67.31M -55.62M
Capital Expenditure -88.00K -84.00K -16.00K -30.00K -37.00K
Sale of Property, Plant, and Equipment -- -- -- 0.00 3.00K
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 86.79M 86.00M 48.04M -30.41M -112.28M
Cash from Investing 86.70M 85.92M 48.03M -30.44M -112.31M
Total Debt Issued -- -- -- 30.00M 30.00M
Total Debt Repaid 0.00 0.00 -739.00K -739.00K -739.00K
Issuance of Common Stock 37.00K 37.00K 7.94M 7.94M 130.56M
Repurchase of Common Stock -82.00K -82.00K -41.00K -422.00K -422.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -42.00K -170.00K -230.00K -706.00K -519.00K
Cash from Financing -87.00K -215.00K 6.93M 36.07M 158.88M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -31.15M -16.77M -31.26M -61.69M -9.06M